series-b
Stage
1
Investors
About
Omeros Corporation is a biopharmaceutical company that discovers and develops novel small-molecule and protein therapeutics targeting previously untapped receptors and enzymes to treat diseases with significant unmet medical needs.
Explore Omeros Corporation's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.